Cochlear Shares Drop Again As Investors Question the Profit Shock
Cochlear Ltd dropped 4.64% to A$95.42 on Thursday, stretching its decline to a third straight session and leaving the Australian hearing-implant maker close to lows reached during last month’s record slide. Volume spiked, too—roughly 671,000 shares changed hands, up from 351,000 the previous day. This shift lands hard for investors still wrestling with how to value a name that used to be pegged as a reliable health-care growth play. Back on April 22, Reuters said Cochlear shares cratered 40.7%—the worst single-day performance the stock’s ever posted—after the company slashed its full-year profit outlook and pointed to sluggish demand in developed markets, Middle East unrest, and currency headwinds.